Dr. Alan N. Langnas, DO

Dr. Langnas practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Langnas' NPI, 1831148899, was assigned on May 8, 2006. Dr. Langnas graduated from Kansas City University of Med & Biosciences, College of Osteo Med in 1982. Dr. Langnas holds Nebraska license 72.

Dr. Langnas' primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Langnas also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Langnas' primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Langnas is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Langnas practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Langnas' primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Langnas is licensed in Nebraska.

CMS data shows 397 Medicare services from Dr. Langnas across 3 procedure codes in 2024, for 75 Medicare patients. Medicare paid $22,495 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 75 Medicare patients who saw Dr. Langnas in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 71% have chronic kidney disease. 32% are also on Medicaid. Their average risk score is 3.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Langnas' median patient age at 60, with 50% women.

In 2024, Dr. Langnas wrote 14 Medicare Part D claims. Every claim was for a generic drug. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $4,566 in total drug cost. In 2016, CMS named 14 claims across 1 drug.

Dr. Langnas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 55 papers to Dr. Langnas, published from 2011 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Liver Transplantation, Intestines and Organ Transplantation. Dr. Langnas has published most often in Pediatr Transplant. Dr. Langnas' most frequent co-authors are David F. Mercer, MD, Wendy J. Grant, MD and Shaheed Merani, FRCSC, MD, PhD.

Dmand AI links Dr. Langnas to 1 clinical trial. Conditions studied include Carcinoma, Hepatocellular and Liver Neoplasms.

CMS Open Payments shows 1 general payment to Dr. Langnas from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. OrganOx Ltd paid the most, $14.

Dr. Langnas graduated from Kansas City University of Med & Biosciences, College of Osteo Med in 1982.